Medicine passport

Betmiga 25 mg 25 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Mirabegron
Strength
25 mg
Form
tablet met verlengde afgifte
ATC code
G04BD12
Registered in
Netherlands · Astellas Pharma Europe B.V.
Prescription
Prescription only
RVG
EU/1/12/809

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

United States 8 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Mirabegron25 mg · Tablet, Film Coated, Extended ReleasePrescription onlyQilu Pharmaceutical Co., Ltd. (+6)67184-0571
Myrbetriq25 mg · Tablet, Film Coated, Extended ReleasePrescription onlyAstellas Pharma US, Inc.0469-2601

Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.

Canada 2 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
APO-MIRABEGRON25 mg · tablet (extended-release)Prescription onlyApotex Inc02564963
MYRBETRIQ25 mg · tablet (extended-release)Prescription onlyAstellas Pharma Canada Inc02402874

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/betmiga-25-mg-25-mg-tablet-met-verlengde-afgifte